Women's Health Issues
Volume 17, Issue 3 , Pages 120-130 , May 2007

Gender Disparities in the Quality of Cardiovascular Disease Care in Private Managed Care Plans

  • Ann F. Chou, PhD, MPH

      Affiliations

    • Department of Health Administration and Policy, College of Public Health and College of Medicine, University of Oklahoma, Oklahoma City, Oklahoma
    • ,
  • Sarah Hudson Scholle, DrPH, MPH

      Affiliations

    • The National Committee for Quality Assurance, Washington, DC
    • Corresponding Author InformationCorrespondence to: Sarah Hudson Scholle, DrPH, MPH, The National Committee for Quality Assurance, 2000 L St., Suite 500, Washington, DC 20036.
    • ,
  • Carol S. Weisman, PhD

      Affiliations

    • College of Medicine, The Pennsylvania State University, Hershey, Pennsylvania
    • ,
  • Arlene S. Bierman, MD, MS

      Affiliations

    • Faculties of Medicine and Nursing, University of Toronto and Centre for Inner City Health Research, St. Michael’s Hospital, Toronto, Ontario, Canada
    • ,
  • Rosaly Correa-de-Araujo, MD, MSc, PhD

      Affiliations

    • Office of the Americas, Office of the Secretary, Office of Global Health Affairs, Rockville, Maryland
    • ,
  • Lori Mosca, MD, MPH, PhD

      Affiliations

    • College of Physicians and Surgeons, Columbia University, New York, New York

Received 22 December 2006 ,Revised 11 January 2007 ,Accepted 13 March 2007.

References 

  1. Abrahamse A, Morrison P, Bolton N. Surname analysis for estimating local concentration of Hispanic and Asians. Population Research Policy & Review. 1994;13:383–398
  2. American Heart Association (AHA). Heart Disease and Stroke Statistics—2004 Update. Dallas: American Heart Association; 2003;
  3. Brown DW, Giles WH, Greenlund KJ, Croft JB. Disparities in cholesterol screening: falling short of a national health objective. Preventive Medicine. 2001;33:517–522
  4. Correa-de-Araujo R, Clancy CM. Catalyzing quality of care improvements for women. Women’s Health Issues. 2006;16:41–43
  5. Correa-de-Araujo R, McDermott K, Moy E. Gender differences across racial and ethnic groups in the quality of care for diabetes. Women’s Health Issues. 2006;16:56–65
  6. Correa-de-Araujo R, Miller GE, Banthin JS, Trinh Y. Gender differences in drug use and expenditures in a privately insured population of older adults. Journal of Women’s Health. 2005;14:73–81
  7. Correa-de-Araujo R, Stevens B, Moy E, Nilasena D, Chesley F, McDermott K. Gender differences across racial and ethnic groups in the quality of care for acute myocardial infarction and heart failure associated with comorbidities. Women’s Health Issues. 2006;16:44–55
  8. Davis KC, Cogswell ME, Rothenberg SL, Koplan JP. Lipid screening in a managed care population. Public Health Representative. 1998;113:346–350
  9. Fremont AM, Bierman A, Wickstrom SL, Bird CE, Shah M, Escarce JJ, et al. Use of geocoding in managed care settings to identify quality disparities. Health Affairs. 2005;24:516–526
  10. Gardner CD, Winkleby MA, Fortmann SP. Population frequency distribution of non-high-density lipoprotein cholesterol (Third National Health and Nutrition Examination Survey [NHANES III], 1988–1994). American Journal of Cardiology. 2000;86:299–304
  11. Goff DC, Bertoni AG, Kramer H, Bonds D, Blumenthal RS, Tsai MY, et al. Dyslipidemia prevalence, treatment, and control in the Multi-Ethnic Study of Atherosclerosis (MESA): Gender, ethnicity, and coronary artery calcium. Circulation. 2006;113:647–656
  12. Harrold LR, Lessard D, Yarzebski J, Gurwitz JH, Gore JM, Goldberg RJ. Age and sex differences in the treatment of patients with initial acute myocardial infarction: A community-wide perspective. Cardiology. 2003;99:39–46
  13. Henderson JT, Weisman CS, Grason H. Are two doctors better than one? (Women’s physician use and appropriate care). Women’s Health Issues. 2002;12:138–149
  14. Hendrix KH, Lackland DT, Egan BM. Cardiovascular risk factor control and treatment patterns in primary care. Managed Care Interface. 2003;16:21–26
  15. Hippisley-Cox J, Pringle M, Crown N, Meal A, Wynn A. Sex inequalities in ischaemic heart disease in general practice: cross sectional survey. British Medical Journal. 2001;322:832
  16. Hollenbeak CS, Weisman CS, Rossi M, Ettinger SM. Gender disparities in percutaneous coronary interventions for acute myocardial infarction in Pennsylvania. Medical Care. 2006;44:24–30
  17. Hu G. Gender difference in all-cause and cardiovascular mortality related to hyperglycaemia and newly-diagnosed diabetes. Diabetologia. 2003;46:608–617
  18. Institute of Medicine (IOM). Unequal treatment: Confronting racial and ethnic disparities in healthcare. Washington, DC: National Academies Press; 2003;
  19. Kim C, Kerr EA, Bernstein SJ, Krein SL. Gender disparities in lipid management: The presence of disparities depends on the quality measure. American Journal of Managed Care. 2006;12:133–136
  20. Legato MJ. Dyslipidemia, gender, and the role of high-density lipoprotein cholesterol: implications of therapy. American Journal of Cardiology. 2000;86:15L–18L
  21. LIPID Study Group. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. New England Journal of Medicine. 1998;339:1349–1357
  22. Massey DS, Denton NA. Hypersegregation in U.S. metropolitan areas: Black and Hispanic segregation along 5 dimensions. Demography. 1989;26:373–391
  23. Massing MW, Foley KA, Carter-Edwards L, Sueta CA, Alexander CM, Simpson RJ. Disparities in lipid management for African Americans and Caucasians with coronary artery disease: A national cross-sectional study. BMC Cardiovascular Disorder. 2004;4:15
  24. Maviglia SM, Teich JM, Fiskio J, Bates DW. Using an electronic medical record to identify opportunities to improve compliance with cholesterol guidelines. Journal of General Internal Medicine. 2001;16:531–537
  25. Mehta RN, Khan IA, Mehta NJ, Ryschon KL, Vasavada BC, Sacchi TJ, et al. Age-related differences in the use of cardiac medications in patients with coronary artery disease. American Journal of Therapy. 2001;8:225–229
  26. Mosca L, Appel LJ, Benjamin EJ, Berra K, Chandra-Strobos N, Fabunmi RP, et al. Evidence-based guidelines for cardiovascular disease prevention in women (American Heart Association scientific statement). ArteriosclerosisThrombosisand Vascular Biology. 2004;24:e29–e50
  27. Mosca L, Ferris A, Fabunmi R, Robertson RM. Tracking women’s awareness of heart disease: An American Heart Association national study. Circulation. 2004;109:573–579
  28. Mosca L, Merz NB, Blumenthal RS, Cziraky MJ, Fabunmi RP, Sarawate C, et al. Opportunity for intervention to achieve American Heart Association guidelines for optimal lipid levels in high-risk women in a managed care setting. Circulation. 2005;111:488–493
  29. National Committee for Quality Assurance (NCQA). (2005). HEDIS 2005: Technical Specifications. Washington, DC: NCQA.
  30. Nau DP, Ellis JJ, Kline-Rogers EM, Mallya U, Eagle KA, Erickson SR. Gender and perceived severity of cardiac disease: evidence that women are “tougher.”. American Journal of Medicine. 2005;118:1256–1261
  31. Nau DP, Mallya U. Sex disparity in the management of dyslipidemia among patients with type 2 diabetes mellitus in a managed care organization. American Journal of Managed Care. 2005;11:69–73
  32. Nerenz DR, Bonham VL, Green-Weir R, Joseph C, Gunter M. Eliminating racial/ethnic disparities in health care: Can health plans generate reports?. Health Affairs. 2002;21:259–263
  33. Panel on DHHS Collection of Race and Ethnic Data. Eliminating health disparities: Measurement and data needs. Washington, DC: National Academies Press; 2004;
  34. Pearson TA. The under treatment of LDL-cholesterol: Addressing the challenge. International Journal of Cardiology. 2000;74(Suppl 1):S23–S28
  35. Pearson TA, Laurora I, Chu H, Kafonek S. The lipid treatment assessment project (L-TAP): A multicenter survey to evaluate the percentages of dyslipidemic patients receiving lipid-lowering therapy and achieving low-density lipoprotein cholesterol goals. Archives of Internal Medicine. 2000;160:459–467
  36. Persell SD, Maviglia SM, Bates DW, Ayanian JZ. Ambulatory hypercholesterolemia management in patients with atherosclerosis (Gender and race differences in processes and outcomes). Journal of General Internal Medicine. 2005;20:123–130
  37. Phillips LS, Ziemer DC, Doyle JP, Barnes CS, Kolm P, Branch WT, et al. An endocrinologist-supported intervention aimed at providers improves diabetes management in a primary care site: Improving primary care of African Americans with diabetes (IPCAAD) 7. Diabetes Care. 2005;28:2352–2360
  38. Pinn VW. Sex and gender factors in medical studies: implications for health and clinical practice. Journal of the American Medical Association. 2003;289:397–400
  39. Qureshi AI, Suri MF, Guterman LR, Hopkins LN. Ineffective secondary prevention in survivors of cardiovascular events in the US population: Report from the Third National Health and Nutrition Examination Survey. Archives of Internal Medicine. 2001;161:1621–1628
  40. Raudenbush SW, Bryk AS. Hierarchical linear models: Applications and data analysis methods. Thousand Oaks, CA: Sage; 2001;
  41. Schulman KA, Berlin JA, Harless W, Kerner JF, Sistrunk S, Gersh BJ, et al. The effect of race and sex on physicians’ recommendations for cardiac catheterization. New England Journal of Medicine. 1999;340:618–626
  42. Sheifer SE, Escarce JJ, Schulman KA. Race and sex differences in the management of coronary artery disease. American Heart Journal. 2000;139:848–857
  43. Sloan KL, Sales AE, Willems JP, Every NR, Martin GV, Sun H, et al. Frequency of serum low-density lipoprotein cholesterol measurement and frequency of results < or = 100 mg/dl among patients who had coronary events (Northwest VA Network Study). American Journal of Cardiology. 2001;88:1143–1146
  44. Smith SC. What is happening in the real world in lipid therapy and is it appropriate? (The need for a paradigm shift). Value Health. 1998;1:204–207
  45. Smith SC, Allen J, Blair SN, Bonow RO, Brass LM, Fonarow GC, et al. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update endorsed by the National Heart, Lung, and Blood Institute. Journal of American College of Cardiologists. 2006;47:2130–2139
  46. Witt BJ, Roger VL. Sex differences in heart disease incidence and prevalence: implications for intervention. Expert Opinion on Pharmacotherapy. 2003;4:675–683

PII: S1049-3867(07)00054-0

doi: 10.1016/j.whi.2007.03.002

Women's Health Issues
Volume 17, Issue 3 , Pages 120-130 , May 2007

Article Tools